GB1547758A
(en)
|
1975-07-29 |
1979-06-27 |
Shell Int Research |
Herbicidal composition
|
JPH01261381A
(ja)
|
1988-04-12 |
1989-10-18 |
Nippon Soda Co Ltd |
オキサ(チア)ジアゾール誘導体、その製造方法及び殺ダニ剤
|
FR2693461B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
US5589452A
(en)
|
1992-07-14 |
1996-12-31 |
Syntex (U.S.A.) Inc. |
Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
|
GB9310635D0
(en)
|
1993-05-21 |
1993-07-07 |
Glaxo Group Ltd |
Chemical compounds
|
DE19517430A1
(de)
|
1995-05-12 |
1996-11-14 |
Boehringer Mannheim Gmbh |
Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode
|
UA51652C2
(uk)
|
1995-06-08 |
2002-12-16 |
Новартіс Аг |
Спосіб гідрування імінів
|
US5723577A
(en)
|
1995-07-13 |
1998-03-03 |
Biomeasure Inc. |
Analogs of parathyroid hormone
|
US6544949B1
(en)
|
1995-07-13 |
2003-04-08 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Analogs of parathyroid hormone
|
US5955574A
(en)
|
1995-07-13 |
1999-09-21 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. |
Analogs of parathyroid hormone
|
US7410948B2
(en)
|
1995-07-13 |
2008-08-12 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Analogs of parathyroid hormone
|
US5969095A
(en)
|
1995-07-13 |
1999-10-19 |
Biomeasure, Inc. |
Analogs of parathyroid hormone
|
WO1997049709A1
(en)
|
1996-06-27 |
1997-12-31 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
US20090264534A1
(en)
|
1996-11-27 |
2009-10-22 |
Dalton James T |
Selective androgen receptor modulators
|
FR2770842B1
(fr)
|
1997-11-13 |
1999-12-17 |
Oreal |
Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
|
EP0922467A3
(en)
|
1997-12-12 |
2000-05-24 |
Takeda Chemical Industries, Ltd. |
Iontophoretic drug delivery
|
JP4154017B2
(ja)
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6159959A
(en)
|
1999-05-06 |
2000-12-12 |
American Home Products Corporation |
Combined estrogen and antiestrogen therapy
|
WO2001036039A2
(en)
|
1999-11-17 |
2001-05-25 |
Novartis Ag |
Iontophoretic transdermal delivery of peptides
|
US6544553B1
(en)
*
|
1999-12-28 |
2003-04-08 |
Watson Pharmaceuticals, Inc. |
Dosage forms and methods for oral delivery of progesterone
|
CA2396059A1
(en)
|
1999-12-30 |
2001-07-12 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
SK9592002A3
(en)
|
2000-01-28 |
2003-12-02 |
Endorech Inc |
A method for reduction or elimination of the incidence of menopausal symptoms, method of treatment or decreasing the risk of an acquiring disease, a pharmaceutical composition and a kit
|
CN1454083A
(zh)
|
2000-06-28 |
2003-11-05 |
布里斯托尔-迈尔斯斯奎布公司 |
选择性雄激素受体调节剂及其鉴定、设计和应用的方法
|
US7214381B2
(en)
|
2000-08-03 |
2007-05-08 |
Antares Pharma Ipl Ag |
Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
KR20030061783A
(ko)
|
2000-08-24 |
2003-07-22 |
더 유니버시티 오브 테네시 리서치 코포레이션 |
선택적 안드로겐 수용체 조절제 및 이들의 사용 방법
|
US7371721B2
(en)
|
2000-09-18 |
2008-05-13 |
Sanos Bioscience A/S |
Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
|
US7186683B2
(en)
|
2000-09-18 |
2007-03-06 |
Sanos Bioscience A/S |
Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
|
NZ525551A
(en)
|
2000-10-26 |
2005-09-30 |
Alza Corp |
Transdermal drug delivery devices having coated microprotrusions
|
WO2003011824A1
(en)
|
2001-07-31 |
2003-02-13 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
EP1418900A4
(en)
|
2001-08-13 |
2006-01-25 |
Merck & Co Inc |
SELECTIVE ESTROGEN RECEPTOR MODULATORS
|
US8853266B2
(en)
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
JP2005524630A
(ja)
|
2002-01-14 |
2005-08-18 |
ノルディック・ビオサイエンス・エー/エス |
エストロゲン受容体を介する軟骨破壊の抑制
|
EP1474127B1
(en)
|
2002-02-15 |
2006-11-15 |
Endorecherche, Inc. |
Biphenyl derivatives and their use as antiandrogenic agents
|
US7772433B2
(en)
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
WO2003091239A1
(en)
|
2002-04-24 |
2003-11-06 |
Merck & Co., Inc. |
Estrogen receptor modulators
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
TW200307553A
(en)
|
2002-05-24 |
2003-12-16 |
Akzo Nobel Nv |
Treatment of post-menopausal complaints in breast cancer patients
|
AU2003251527A1
(en)
|
2002-06-13 |
2003-12-31 |
Beth Israel Deaconess Medical Center, Inc. |
Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
|
CA2492138C
(en)
|
2002-07-12 |
2011-01-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
N-phenyl-(2r,5s)dimethylpiperazine derivative
|
US7649001B2
(en)
|
2002-08-12 |
2010-01-19 |
Takeda Pharmaceutical Company Limited |
Fused benzene derivative and use
|
US7662404B2
(en)
|
2002-10-31 |
2010-02-16 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
|
US7383084B2
(en)
|
2002-10-31 |
2008-06-03 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
US8133505B2
(en)
|
2002-10-31 |
2012-03-13 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
IL152574A
(en)
|
2002-10-31 |
2009-09-22 |
Transpharma Medical Ltd |
A system for passing through the skin of dry items or dried medicines
|
CA2504044A1
(en)
|
2002-11-01 |
2004-05-21 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
UA79504C2
(en)
|
2002-11-07 |
2007-06-25 |
Organon Nv |
Indols for treating diseases associated with androgen receptors
|
EP1567487A4
(en)
|
2002-11-15 |
2005-11-16 |
Bristol Myers Squibb Co |
OPEN-CHAINED, PROLYL-FROSTED MODULATORS OF ANDROGEN RECEPTOR FUNCTION
|
EP1577288B1
(en)
*
|
2002-12-26 |
2014-07-23 |
Eisai R&D Management Co., Ltd. |
Selective estrogen receptor modulators
|
EP1603858A2
(en)
|
2003-03-11 |
2005-12-14 |
NeuroSearch A/S |
Kcnq channel modulating compounds and their pharmaceutical use
|
EP1654221A2
(en)
|
2003-06-10 |
2006-05-10 |
Smithkline Beecham Corporation |
Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
|
US20060142387A1
(en)
|
2003-06-10 |
2006-06-29 |
Rodolfo Cadilla |
Chemical compounds
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
FI20030958A0
(fi)
|
2003-06-27 |
2003-06-27 |
Orion Corp |
Uusia yhdisteitä
|
TW200518771A
(en)
|
2003-06-30 |
2005-06-16 |
Alza Corp |
Formulations for coated microprojections containing non-volatile counterions
|
EP1643978A1
(en)
*
|
2003-07-04 |
2006-04-12 |
Nycomed Danmark A/S |
Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
|
AU2004272007B2
(en)
|
2003-09-10 |
2009-05-28 |
Merck Sharp & Dohme Corp. |
17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
GB0324551D0
(en)
|
2003-10-21 |
2003-11-26 |
Karobio Ab |
Novel compounds
|
ES2377647T3
(es)
|
2003-10-31 |
2012-03-29 |
Alza Corporation |
Aplicador auto-actuado para ordenamiento de microproyecciones
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
MXPA06005510A
(es)
|
2003-11-13 |
2006-12-14 |
Johnson & Johnson |
Composicion y aparato para distribucion transdermica.
|
CA2545048A1
(en)
|
2003-11-20 |
2005-06-02 |
Warner-Lambert Company Llc |
Androgen receptor modulators
|
IL159273A0
(en)
|
2003-12-09 |
2004-06-01 |
Transpharma Medical Ltd |
Transdermal delivery system for sustained release of polypeptides
|
US20070196395A1
(en)
|
2003-12-12 |
2007-08-23 |
Mackerell Alexander |
Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
|
CN102358750B
(zh)
|
2004-01-07 |
2015-11-25 |
恩多研究公司 |
螺旋12定向的甾族药品
|
AU2005207821B2
(en)
|
2004-01-22 |
2011-02-10 |
Eli Lilly And Company |
Selective estrogen receptor modulators for the treatment of vasomotor symptoms
|
IL160033A0
(en)
|
2004-01-25 |
2004-06-20 |
Transpharma Medical Ltd |
Transdermal delivery system for polynucleotides
|
US20050182105A1
(en)
|
2004-02-04 |
2005-08-18 |
Nirschl Alexandra A. |
Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
|
US7820702B2
(en)
|
2004-02-04 |
2010-10-26 |
Bristol-Myers Squibb Company |
Sulfonylpyrrolidine modulators of androgen receptor function and method
|
JP4805909B2
(ja)
|
2004-03-03 |
2011-11-02 |
スミスクライン ビーチャム コーポレーション |
選択的アンドロゲン受容体モジュレーターとしてのアニリン誘導体
|
US7625923B2
(en)
|
2004-03-04 |
2009-12-01 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
US7388027B2
(en)
|
2004-03-04 |
2008-06-17 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
GB0405033D0
(en)
|
2004-03-05 |
2004-04-07 |
Karobio Ab |
Novel pharmaceutical compositions
|
US8519158B2
(en)
|
2004-03-12 |
2013-08-27 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
JP2007223901A
(ja)
|
2004-03-24 |
2007-09-06 |
Takeda Chem Ind Ltd |
複素環化合物およびその用途
|
JP2007532550A
(ja)
|
2004-04-08 |
2007-11-15 |
メルク エンド カムパニー インコーポレーテッド |
アンドロゲン受容体モジュレーターとしての17−β−アセトアミド−4−アザステロイド
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
EP1753749B1
(en)
|
2004-05-03 |
2014-07-30 |
Janssen Pharmaceutica NV |
Novel indole derivatives as selective androgen receptor modulators (sarms)
|
MXPA06013115A
(es)
|
2004-05-11 |
2007-02-28 |
Pfizer Prod Inc |
Derivados de benzonitrilo para tratar la fragilidad musculoesqueletica.
|
JP5007427B2
(ja)
|
2004-05-13 |
2012-08-22 |
アルザ コーポレイション |
副甲状腺ホルモン剤の経皮送達のための装置および方法
|
JP2007538085A
(ja)
|
2004-05-17 |
2007-12-27 |
アカディア ファーマシューティカルズ インコーポレイティド |
アンドロゲン受容体モジュレーターおよびそれを用いて疾患を治療する方法
|
US20080119456A1
(en)
|
2004-05-29 |
2008-05-22 |
Trond Ulven |
Substituted Thiazoleacetic Acid as Crth2 Ligands
|
ATE552235T1
(de)
|
2004-06-07 |
2012-04-15 |
Univ Tennessee Res Foundation |
Selektive androgen-rezeptor-modulator und anwendungsverfahren dafür
|
WO2006031715A2
(en)
|
2004-09-10 |
2006-03-23 |
Janssen Pharmaceutica N.V. |
Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms)
|
ES2366193T3
(es)
|
2004-09-20 |
2011-10-18 |
Janssen Pharmaceutica Nv |
Nuevos derivados que contienen heteroátomos tetracíclicos útiles como moduladores de receptores de hormonas esteroideas sexuales.
|
JP4953456B2
(ja)
|
2004-09-30 |
2012-06-13 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
選択的アンドロゲン受容体モジュレーター(sarm)として有用な新規なベンゾイミダゾール誘導体
|
US8143425B2
(en)
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
JP2008515998A
(ja)
|
2004-10-13 |
2008-05-15 |
スミスクライン ビーチャム コーポレーション |
化合物
|
CA2585276A1
(en)
|
2004-10-29 |
2006-06-08 |
Merck & Co., Inc. |
N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators
|
CA2587678C
(en)
|
2004-11-16 |
2013-05-21 |
Janssen Pharmaceutica N.V. |
Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
|
JP2008520331A
(ja)
|
2004-11-18 |
2008-06-19 |
トランスファーマ メディカル リミテッド |
薬剤の経皮的送達のためのマイクロチャネル形成とイオントフォレーシスの組合せ
|
EP1817025A2
(en)
|
2004-11-23 |
2007-08-15 |
PTC Therapeutics, Inc. |
Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
|
CA2594340C
(en)
|
2005-01-10 |
2015-11-10 |
Acadia Pharmaceuticals Inc. |
Aminophenyl derivatives as selective androgen receptor modulators
|
US20080194536A1
(en)
|
2005-04-15 |
2008-08-14 |
Marlys Hammond |
Cyanoarylamines
|
WO2006124447A2
(en)
|
2005-05-13 |
2006-11-23 |
Eli Lilly And Company |
Substituted n-arylpyrrolidines as selective androgen receptor modulators
|
JP2008546643A
(ja)
|
2005-06-06 |
2008-12-25 |
スミスクライン ビーチャム コーポレーション |
4−置換アリールアミン誘導体および医薬組成物におけるその使用
|
US7829589B2
(en)
|
2005-06-10 |
2010-11-09 |
Elixir Pharmaceuticals, Inc. |
Sulfonamide compounds and uses thereof
|
US7709516B2
(en)
|
2005-06-17 |
2010-05-04 |
Endorecherche, Inc. |
Helix 12 directed non-steroidal antiandrogens
|
JP5204650B2
(ja)
|
2005-06-24 |
2013-06-05 |
イーライ リリー アンド カンパニー |
アンドロゲン受容体調節物質として有用なテトラヒドロカルバゾール誘導体
|
US20090227571A1
(en)
|
2005-07-01 |
2009-09-10 |
Ligand Pharmaceuticals Incorporated |
Androgen Receptor Modulator Compounds and Methods
|
EP1911743B8
(en)
|
2005-08-01 |
2013-01-16 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound
|
JP2008303145A
(ja)
|
2005-09-22 |
2008-12-18 |
Takeda Chem Ind Ltd |
Grk阻害剤からなる強心薬
|
US7776859B2
(en)
|
2005-10-14 |
2010-08-17 |
Bristol-Myers Squibb Company |
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
|
WO2007061781A1
(en)
|
2005-11-18 |
2007-05-31 |
3M Innovative Properties Company |
Coatable compositions, coatings derived therefrom and microarrays having such coatings
|
TW200730505A
(en)
|
2005-12-07 |
2007-08-16 |
Merck & Co Inc |
Polymorphs of an androgen receptor modulator
|
WO2007084247A2
(en)
|
2005-12-28 |
2007-07-26 |
Alza Corporation |
Stable therapeutic formulations
|
KR101514989B1
(ko)
|
2006-01-24 |
2015-04-24 |
얀센 파마슈티카 엔.브이. |
선택적 안드로겐 수용체 조절자(sarms)로서 2―치환된 벤즈이미다졸
|
US8501814B2
(en)
|
2006-03-03 |
2013-08-06 |
Orion Corporation |
Selective androgen receptor modulators
|
US20080039775A1
(en)
|
2006-03-15 |
2008-02-14 |
Alza Corporation |
Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents to Prevent or Treat Osteopenia
|
US9119945B2
(en)
|
2006-04-20 |
2015-09-01 |
3M Innovative Properties Company |
Device for applying a microneedle array
|
WO2008002490A2
(en)
|
2006-06-23 |
2008-01-03 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
MX2009000385A
(es)
|
2006-07-12 |
2009-04-06 |
Univ Tennessee Res Foundation |
Acil-anilidas sustituidas y metodos de uso de las mismas.
|
AU2007275736A1
(en)
|
2006-07-19 |
2008-01-24 |
Osurf (Ohio State University Research Foundation) |
Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
|
AU2007287070C1
(en)
|
2006-08-24 |
2013-02-14 |
University Of Tennessee Research Foundation |
Substituted acylanilides and methods of use thereof
|
ES2452343T3
(es)
|
2006-09-29 |
2014-04-01 |
Glaxosmithkline Llc |
Compuestos de indol sustituidos
|
US7803770B2
(en)
|
2006-10-03 |
2010-09-28 |
Radius Health, Inc. |
Method of treating osteoporosis comprising administration of PTHrP analog
|
CN101578093B
(zh)
|
2006-10-03 |
2011-09-14 |
半径健康公司 |
骨合成代谢蛋白质的药物递送方法
|
WO2008044033A1
(en)
|
2006-10-11 |
2008-04-17 |
Astrazeneca Ab |
Amide derivatives
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
WO2008121602A1
(en)
|
2007-03-29 |
2008-10-09 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008124000A2
(en)
|
2007-04-02 |
2008-10-16 |
Ligand Pharmaceuticals Incorporated |
Thiazole derivatives as androgen receptor modulator compounds
|
US9284345B2
(en)
|
2007-04-12 |
2016-03-15 |
Endorecherche, Inc. |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
|
US7696227B2
(en)
|
2007-04-13 |
2010-04-13 |
Regents Of The University Of California |
Small-molecule inhibitors of the androgen receptor
|
EP2146689B1
(en)
|
2007-04-16 |
2020-08-12 |
Corium, Inc. |
Solvent-cast microneedle arrays containing active
|
AR067823A1
(es)
|
2007-08-07 |
2009-10-21 |
Takeda Pharmaceutical |
Compuestos de amina ciclica
|
WO2009054988A1
(en)
|
2007-10-23 |
2009-04-30 |
Alza Corporation |
Transdermal sustained release drug delivery
|
US20110105554A1
(en)
|
2007-11-21 |
2011-05-05 |
Kinaris Biomedicals Gmbh |
Means for treating myosin-related diseases
|
CA2709514A1
(en)
|
2007-12-21 |
2009-07-02 |
Astrazeneca Ab |
Bicyclic derivatives for use in the treatment of androgen receptor associated conditions
|
US8268872B2
(en)
|
2008-02-22 |
2012-09-18 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
EP2260028B1
(en)
|
2008-02-22 |
2014-05-07 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
WO2009133861A1
(ja)
|
2008-04-28 |
2009-11-05 |
武田薬品工業株式会社 |
環状アミン化合物
|
US20110124617A1
(en)
|
2008-05-09 |
2011-05-26 |
Lyttle C Richard |
Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent
|
CA2724629C
(en)
|
2008-05-16 |
2014-08-19 |
Eli Lilly And Company |
Tetrahydrocyclopenta[b]indole androgen receptor modulators
|
WO2010022176A1
(en)
|
2008-08-19 |
2010-02-25 |
Ferring International Center S.A. |
Methods of treatment for skeletal conditons
|
RU2561057C2
(ru)
|
2008-11-04 |
2015-08-20 |
Аска Фармасьютикал Ко., Лтд. |
Водная композиция, содержащая фолликулостимулирующий гормон
|
EP2383013A4
(en)
|
2008-12-26 |
2012-11-28 |
Hisamitsu Pharmaceutical Co |
MICRO NEEDLE DEVICE
|
US20100226966A1
(en)
|
2009-03-03 |
2010-09-09 |
Daddona Peter E |
Method for transdermal controlled release drug delivery
|
WO2010118287A1
(en)
|
2009-04-10 |
2010-10-14 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
KR102375647B1
(ko)
|
2009-10-16 |
2022-03-17 |
가부시키가이샤 한도오따이 에네루기 켄큐쇼 |
액정 표시 장치 및 이를 구비한 전자 장치
|
US20110172609A1
(en)
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
MX338831B
(es)
|
2010-02-04 |
2016-05-03 |
Radius Health Inc |
Moduladores selectivos de receptores de androgenos.
|
IE20100174A1
(en)
|
2010-03-25 |
2012-02-29 |
Trinity College Dublin |
Transdermal administration of peptides
|
JP6327852B2
(ja)
|
2010-05-04 |
2018-05-23 |
コリウム インターナショナル, インコーポレイテッド |
微小突起アレイを使用した副甲状腺ホルモンの経皮送達のための方法及びデバイス
|
MX342898B
(es)
|
2010-05-12 |
2016-10-18 |
Radius Health Inc * |
Regimen terapéutico de la sal de diclorhidrato del (r) -6-(2-(etil (4-2(etilamino) etil) bencil) amino)-4-metoxifenil)-5, 6,7,8-tetrahidronaftaleno-2-ol.
|
WO2011150144A2
(en)
|
2010-05-28 |
2011-12-01 |
3M Innovative Properties Company |
Aqueous formulations for coating microneedle arrays
|
US8642632B2
(en)
|
2010-07-02 |
2014-02-04 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
EP2621901B1
(en)
|
2010-09-28 |
2015-07-29 |
Radius Health, Inc |
Selective androgen receptor modulators
|
WO2012075375A1
(en)
|
2010-12-02 |
2012-06-07 |
Lanco Biosciences, Inc. |
Delivery of parathyroid hormones by microinjection systems
|
CN103917242A
(zh)
|
2011-04-22 |
2014-07-09 |
半径健康公司 |
PTH、PTHrP和相关肽的药物递送方法
|
CN104080506B
(zh)
|
2011-11-30 |
2017-03-08 |
3M创新有限公司 |
包含肽治疗剂和氨基酸的微针装置以及制备和使用其的方法
|